<DOC>
	<DOCNO>NCT00079807</DOCNO>
	<brief_summary>HIV associate painful peripheral neuropathy . Disability often significant . Alpha-Lipoic Acid 's antioxidant property may benefit condition .</brief_summary>
	<brief_title>Painful HIV Neuropathy Alpha-Lipoic Acid</brief_title>
	<detailed_description>HIV associate painful distal peripheral polyneuropathy 35-50 % without AIDS 70 % advanced disease . The condition progressive may halt disease remission . Disability often significant . Peripheral nerve axon sensory neuron cell body dorsal root ganglion principal target process lead symptom . Alpha-lipoic acid occur naturally every cell body . In high concentration act anti-oxidant regenerates anti-oxidants promotes glutathione synthesis . Clinical study diabetic neuropathy show significant benefit daily oral dos well-tolerated . This placebo-controlled study design evaluate effect daily oral alpha-lipoic acid supplement ( 600mg , three time per/day ) plus standard medical care treatment painful HIV-associated neuropathy 24-week period adult subject . Possible benefit study include reduction pain disability , reduce use medication , enhance cellular metabolism .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>HIVseropositive Distal peripheral sensory neuropathy diagnose neurologist pain paresthesia , without numbness weakness Able understand participate protocol activity Able give inform consent Under care UNC ID Clinical physician least 2 month Able document pain characteristic , use pain medication , assessment instrument characteristic On stable antiretroviral therapy ( none ) 12 week prior enrollment No change peripheral neuropathy pharmacologic treatment 12 week prior enrollment Any significant cognitive impairment psychosis Pregnancy anticipate pregnancy ( woman childbearing potential must agree use birth control duration study ) Undergoing current treatment malignancy , include chemotherapy radiation therapy within past year Concurrent prior use aLA Known nonHIV risk factor peripheral neuropathy , DM , B12/folate deficiency ; thyroid dysfunction ; hx exposure lead , mercury , arsenic , thallium ( prior diagnostic test permit ) , heavy metal complex hydrocarbon Use metronidazole , isoniazid furantoins Suspected documented thiamin deficiency Active alcoholism Allergy aLA Hx 'significant ' use antioxidant supplement two month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>HIV</keyword>
	<keyword>Peripheral neuropathy</keyword>
	<keyword>Alpha-Lipoic Acid</keyword>
	<keyword>ALA</keyword>
	<keyword>Complementary Therapies</keyword>
</DOC>